- Report
- October 2024
- 182 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- December 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- March 2025
- 196 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- July 2024
- 174 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- June 2024
- 260 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Report
- May 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- November 2020
- 260 Pages
Global
From €1307EUR$1,375USD£1,098GBP
€2614EUR$2,750USD£2,196GBP
- Report
- December 2019
- 165 Pages
Global
From €1307EUR$1,375USD£1,098GBP
€2614EUR$2,750USD£2,196GBP
- Drug Pipelines
- November 2023
- 30 Pages
United States
From €2614EUR$2,750USD£2,196GBP
- Report
- August 2022
- 30 Pages
Global
From €2614EUR$2,750USD£2,196GBP
- Report
- February 2024
- 111 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- May 2023
- 140 Pages
Global
From €4705EUR$4,949USD£3,952GBP

Analgesics are a class of drugs used to relieve pain. Non-opioid analgesics are a subset of analgesics that do not contain opioids, and are used to treat mild to moderate pain. Non-opioid analgesics are typically used for short-term pain relief, such as headaches, muscle aches, and menstrual cramps. Common non-opioid analgesics include acetaminophen, ibuprofen, and naproxen. These drugs are available over-the-counter, and are generally considered safe when taken as directed.
Non-opioid analgesics are widely used, and the market for these drugs is growing. The market is driven by an increasing demand for pain relief, as well as an increasing awareness of the risks associated with opioid use. Non-opioid analgesics are seen as a safer alternative to opioids, and are often recommended by healthcare providers.
Some companies in the non-opioid analgesics market include Johnson & Johnson, Bayer, Pfizer, and GlaxoSmithKline. These companies produce a variety of non-opioid analgesics, including acetaminophen, ibuprofen, and naproxen. Show Less Read more